• TSPAN18 Protects STIM1 to Drive Bone Metastasis in Prostate

  2026-06-19

  Zhou et al. uncover a previously unrecognized mechanism in which TSPAN18 stabilizes STIM1 protein by blocking TRIM32-mediated ubiquitination, thereby facilitating calcium signaling and promoting bone metastasis in prostate cancer. This work highlights TSPAN18 as a promising therapeutic target and provides mechanistic clarity for researchers studying metastatic progression and calcium signaling in hormone-responsive cancers.

• Standardized Whole-Blood Stimulation Reveals Immunometabolic

  2026-06-18

  This protocol study establishes a standardized workflow for analyzing immune responses in human whole blood under precise metabolic modulation. Its innovation lies in rigorously linking metabolic pathway inhibition to cytokine production, providing a robust platform for reproducible immunometabolism research and the exploration of targeted immune interventions.

• Recombinant Human Growth Hormone: Unveiling the IGFBP2-THBS1

  2026-06-18

  Explore the molecular intricacies of Recombinant Human Growth Hormone (GH) and its pivotal IGFBP2-THBS1 axis in bone growth research. This in-depth analysis offers unique insights into somatotropin’s mechanism, extending beyond assay workflows to shape future experimental design.

• Gestational Nano-Plastic Exposure Impairs Adult Male Reprodu

  2026-06-17

  A recent omics-driven study demonstrates that gestational polystyrene nano-plastics (PS-NPs) exposure leads to testicular injury and reproductive dysfunction in adult male offspring. By integrating transcriptomics and metabolomics, the research reveals a partial adverse outcome pathway linking molecular disruptions to impaired spermatogenesis, informing both environmental toxicology and reproductive health research.

• GSH and GSSG Assay Kit: Precision Redox State Analysis in Tu

  2026-06-17

  The GSH and GSSG Assay Kit from APExBIO delivers robust, quantitative detection of reduced and oxidized glutathione, accelerating research into redox biology and tumor immunometabolism. Discover stepwise workflows, troubleshooting strategies, and protocol enhancements that empower your oxidative stress and redox state analyses across diverse biological models.

• Tiamulin (Thiamutilin): Optimizing Veterinary Antibiotic Wor

  2026-06-16

  Tiamulin (Thiamutilin) stands out for its dual antibacterial and anti-inflammatory action, making it a cornerstone in advanced veterinary research for pigs and poultry. This article delivers actionable protocols, troubleshooting strategies, and translational insights to maximize experimental reliability and clinical relevance.

• Etoposide (VP-16): Expanding DNA Damage Research with Nuclea

  2026-06-16

  Explore Etoposide (VP-16) as a topoisomerase II inhibitor for advanced DNA damage and apoptosis studies. This article uniquely examines the intersection of Etoposide-induced double-strand breaks with novel nuclear cGAS regulatory pathways, offering practical guidance for precision assay design.

• Linoleic Acid (C18:2): Translational Control and Experimenta

  2026-06-15

  Explore the pivotal role of Linoleic Acid (C18:2) in translational control, oxidative stress modeling, and advanced cell assays. Discover unique mechanistic links to lipid signaling that set this guide apart for researchers.

• 5-Azacytidine (A1907): Workflow Solutions for Epigenetic Ass

  2026-06-15

  This article translates real laboratory scenarios into actionable guidance for optimizing cell viability and epigenetic assays using 5-Azacytidine (SKU A1907). Readers will find evidence-based Q&A blocks, protocol parameters, and vendor analysis to enhance reproducibility, sensitivity, and interpretability of results. The unique positioning of 5-Azacytidine as a reliable DNMT inhibitor is grounded in both experimental data and practical lab experience.

• Difloxacin HCl: Optimizing Antimicrobial & MDR Research Work

  2026-06-14

  Difloxacin HCl, a potent quinolone antimicrobial antibiotic, uniquely empowers researchers to tackle both bacterial susceptibility and multidrug resistance reversal within a single workflow. This article provides a practical, evidence-based roadmap for leveraging its dual-action mechanism in advanced microbiology and oncology assays.

• Difloxacin HCl: Quinolone Antimicrobial Antibiotic in Bench

  2026-06-13

  Difloxacin HCl stands out for its dual role in both antimicrobial susceptibility testing and multidrug resistance reversal, making it indispensable for translational research. This guide translates experimental protocols, troubleshooting tips, and new mechanistic insights into actionable steps for microbiology and oncology labs.

• Mubritinib-HSA Binding: Mechanistic Insights for Drug Delive

  2026-06-12

  This article examines the molecular recognition mechanisms between the mitochondrial electron transport chain inhibitor mubritinib and human serum albumin (HSA), as elucidated by a recent multispectroscopic and docking study. These findings inform the broader pharmacological understanding of drug-protein interactions, with direct implications for the design and optimization of anti-proliferative agents in cancer therapy.

• Ionophore Toxicity Mechanisms and Tiamulin Interactions in A

  2026-06-12

  This review synthesizes advances in understanding the clinical and molecular mechanisms of ionophore toxicity in animals, emphasizing the complex interplay between ionophore pharmacology and veterinary drug interactions. The inclusion of Tiamulin’s modulatory effects on ionophore biotransformation provides actionable insights for researchers studying drug safety and efficacy in veterinary settings.

• Merimepodib (VX-497): IMPDH Inhibition in Antiviral and Immu

  2026-06-11

  Merimepodib (VX-497) stands out as a selective, reversible, and orally bioavailable IMPDH inhibitor, enabling precise dissection of nucleotide metabolism across oncology, virology, and immunology. Its robust antiviral and immunosuppressive profiles—now extended by recent PEDV mechanistic insights—make it a pivotal tool for host-directed therapeutic research.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-06-11

  Wang et al. elucidate the METTL16-SENP3-LTF axis as a key driver of ferroptosis resistance and tumorigenesis in hepatocellular carcinoma. The study provides mechanistic insights into RNA methylation’s role in iron metabolism and highlights potential molecular targets for sensitizing HCC to ferroptosis-based therapies.

15122 records 1/1009 page Next 12345 下5页 Last page